NICE recommends access to venclyxto for adult leukaemia
NICE has issued a final appraisal determination recommending that venclyxto is made available to patients with chronic lymphocytic leukaemia...
List view / Grid view
NICE has issued a final appraisal determination recommending that venclyxto is made available to patients with chronic lymphocytic leukaemia...
The CSV and Data Integrity Compliance Congress offers customisable, top-notch training for FDA compliance challenges.
Researchers have collaborated to design a smart bandage that could eventually heal chronic wounds...
Researchers have developed a technology - that can quickly identify potential drug combinations to control parasitic worms...
TK216-vincristine combination appears to halt the ability of Ewing sarcoma to grow and progress...
Lab Innovations – the UK’s only dedicated showcase for laboratory, analytical and biotech equipment – returns to the NEC, Birmingham, for its sixth consecutive year on the 1st and 2nd of November 2017.
Alcohol aversion drug disulfiram may combat chemotherapy resistance in non-small cell lung cancer...
• Datwyler Sealing Solutions presents the company’s new health care offering at CPhI Worldwide • First Line – Manufacturing concept for high-quality elastomer components
A group of scientists have created a computer model to analyse amyloid beta accumulation using published papers and clinical studies...
Leading organisations have developed specifications, which will promote more streamline and reproducible bioinformatics research for clinical trials...
Research shows the Parkinson's disease drug carbidopa displays significant anticancer effects in human cell lines...
The FDA has approved Verzenio to treat advanced or metastatic breast cancer that has progressed after taking therapy...
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the EC has granted marketing authorisation for Dupixent for use in adults with moderate-to-severe atopic dermatitis...
Researchers find ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer...
Scientists have combined a hydrophobic material polylactic acid and a biodegradable polymer calcium carbonate to encapsulate water-soluble drugs...